+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients



The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients



European Respiratory Journal 44(2): 527-529




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056310431

Download citation: RISBibTeXText

PMID: 24791831

DOI: 10.1183/09031936.00011714


Related references

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 12: 907-922, 2017

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. International Journal of Chronic Obstructive Pulmonary Disease 14: 531-546, 2019

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 13: 3203-3231, 2018

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. International Journal of Chronic Obstructive Pulmonary Disease 10: 1093-1102, 2015

Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice. Chest 155(6): 1158-1165, 2019

P59Factors influencing step-up to lama+laba/ics in Copd patients initially on lama monotherapy: a thin database study. Thorax 71(Suppl 3): A116.1-A116, 2016

LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients. Evidence-BasedMedicine21(6):222, 2016

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17(5): 509-517, 2018

Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA. Respiratory Medicine 139: 65-71, 2018

LAMA/LABA fixed dose combination for treatment of COPD. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(5): 820-826, 2016

LAMA/LABA supports physical activity in COPD patients. Mmw Fortschritte der Medizin 158(2): 71, 2016

LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. European Respiratory Review 26(143):, 2017

Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA. International Journal of Chronic Obstructive Pulmonary Disease 11: 263-271, 2016

POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes. Chest 154(4): 746-748, 2018

Characteristics and health care resource use of subjects with COPD in the year before initiating LAMA monotherapy or LAMA+LABA combination therapy: A U.S. database study. Managed Care 27(5): 40-47, 2018